SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-032676
Filing Date
2020-12-03
Accepted
2020-12-03 16:55:40
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5377
  Complete submission text file 0000899243-20-032676.txt   7435
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 201367503
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ENERGIEWEG 1 MIJDRECHT P7 3641
Business Address ENERGIEWEG 1 MIJDRECHT P7 3641 00 31 297 280 666
Bayer World Investments B.V. (Reporting) CIK: 0001820027 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 201367502